Proprietary Data, Expert Analysis And Thought-Provoking Insights
The DT Clinical Trial Digital Tracker Survey is a methodology to assess the current state of digital technology adoption by clinical trial sites globally. Our inaugural survey last year showed that many clinical trial sites were still reluctant to integrate digital technologies into their processes and that cost, complexity, and finding the right technologies were the main barriers to digital adoption. Our second wave of results show that digital adoption is increasing and that concerns about patients’ ability to use digital tools is now the main barrier to digital adoption. We also found that the clinical research sector has shown resilience in its response to the COVID-19 pandemic, initiating more trials and getting more drugs approved for market use. It’s more crucial than ever for pharma firms to sustain this positive momentum by aligning clinical ops teams to the needs of clinical trial sites and patients, by prioritizing the assessment and understanding of their experience and challenges.